The rapidly aging population, increase in infectious diseases, and the advent of blockbuster vaccines have accelerated the growth of the global vaccine market.

The growing vaccine industry is resulting in improved profitability, new research and manufacturing technology development, and new funding opportunities.

In recent years, the development of therapeutic vaccines that can treat diseases that have already occurred (viruses, cancers, etc.) is also on the rise,
following preventive vaccines that stop infectious diseases in advance.